Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genpact (G) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Genpact (G) over the last 17 years, with Q3 2025 value amounting to $7.0 million.

  • Genpact's Asset Writedowns and Impairment changed N/A to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.8 million, marking a year-over-year increase of 13229.89%. This contributed to the annual value of $13.8 million for FY2024, which is 24697.16% up from last year.
  • According to the latest figures from Q3 2025, Genpact's Asset Writedowns and Impairment is $7.0 million.
  • In the past 5 years, Genpact's Asset Writedowns and Impairment registered a high of $31.5 million during Q4 2022, and its lowest value of -$1.4 million during Q3 2023.
  • Moreover, its 5-year median value for Asset Writedowns and Impairment was $3.3 million (2023), whereas its average is $7.3 million.
  • Within the past 5 years, the most significant YoY rise in Genpact's Asset Writedowns and Impairment was 350864.86% (2022), while the steepest drop was 16368.64% (2022).
  • Genpact's Asset Writedowns and Impairment (Quarter) stood at -$925000.0 in 2021, then skyrocketed by 3508.65% to $31.5 million in 2022, then crashed by 103.5% to -$1.1 million in 2023, then surged by 228.04% to $1.4 million in 2024, then soared by 397.8% to $7.0 million in 2025.
  • Its Asset Writedowns and Impairment stands at $7.0 million for Q3 2025, versus $11.1 million for Q2 2025 and $7.3 million for Q1 2025.